MedPath

Validation of CT Angiography and Magnetic Resonance Imaging protocols for characterization and quantification of atherosclerosis in carotid arteries.

Completed
Conditions
atherosclerosis
10003216
Registration Number
NL-OMON39409
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

- Patients with cerebrovascular symptoms (TIA, minor stroke) in the last six
months.
- CTA of the carotid arteries at the Erasmus Medical Center during the last 2
months (CTA is performed for clinical work-up).
- Scheduled endarterectomy of a carotid artery
- Signed informed consent
- At least 50 years old
- Patients who have a documented allergy to MRI contrast media are eligible for MRI, but will not undergo a contrast-enhanced scan.
- Patients with a renal clearance (eGFR) <30 ml/minute are eligible for MRI, but will not undergo contrast-enhanced MRI.

Exclusion Criteria

- Woman who are pregnant or lactating.
- Patients who are hemodynamically unstable.
- Having any physical or mental status that interferes with the informed
consent procedure.
- Not being able to remain lying down for at least 40-45 min (e.g. patients with
unstable angina, dyspnea at rest, severe pain at rest, severe back pain)
- Contraindications for MRI (e.g. claustrophobia, pacemaker,*)

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>- MRI Plaque quantification by basic morphological parameters (Plaque burden,<br /><br>Lumen, Outer wall area) and plaque<br /><br>composition (Fibrous cap, ulcerations, lipid rich necrotic core (LC/NR),<br /><br>calcifications, intraplaque hemorrhage)<br /><br>- Histology from the removed atherosclerotic plaque</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>NA</p><br>
© Copyright 2025. All Rights Reserved by MedPath